Cargando…
Anti-Arrhythmic Effects of Sodium-Glucose Co-Transporter 2 Inhibitors
Arrhythmias are clinically prevalent with a high mortality rate. They impose a huge economic burden, thereby substantially affecting the quality of life. Sodium-glucose co-transporter 2 inhibitor (SGLT2i) is a new type of hypoglycemic drug, which can regulate blood glucose level safely and effective...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263384/ https://www.ncbi.nlm.nih.gov/pubmed/35814223 http://dx.doi.org/10.3389/fphar.2022.898718 |